118 related articles for article (PubMed ID: 16420954)
1. Are there differences in clinical and laboratory parameters between children and adults with American visceral leishmaniasis?
Caldas AJ; Costa J; Aquino D; Silva AA; Barral-Netto M; Barral A
Acta Trop; 2006 Mar; 97(3):252-8. PubMed ID: 16420954
[TBL] [Abstract][Full Text] [Related]
2. Treatment of paediatric visceral leishmaniasis: amphotericin B or pentavalent antimony compounds?
Kafetzis DA; Velissariou IM; Stabouli S; Mavrikou M; Delis D; Liapi G
Int J Antimicrob Agents; 2005 Jan; 25(1):26-30. PubMed ID: 15620822
[TBL] [Abstract][Full Text] [Related]
3. Visceral childhood leishmaniasis in southern Turkey: experience of twenty years.
Dursun O; Erişir S; Yeşilipek A
Turk J Pediatr; 2009; 51(1):1-5. PubMed ID: 19378883
[TBL] [Abstract][Full Text] [Related]
4. Effect of meglumine antimoniate on the pancreas during treatment of visceral leishmaniasis in children.
Shahian M; Alborzi A
Med Sci Monit; 2009 Jun; 15(6):CR290-3. PubMed ID: 19478699
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for relapse of visceral leishmaniasis in Georgia.
Kajaia M; Morse DL; Kamkamidze G; Butsashvili M; Chubabria G; Zenaishvili O; Kokaia N; McNutt LA
Trop Med Int Health; 2011 Feb; 16(2):186-92. PubMed ID: 21143353
[TBL] [Abstract][Full Text] [Related]
6. Rapid clearance of circulating Leishmania kinetoplast DNA after treatment of visceral leishmaniasis.
Disch J; Oliveira MC; Orsini M; Rabello A
Acta Trop; 2004; 92(3):279-83. PubMed ID: 15533299
[TBL] [Abstract][Full Text] [Related]
7. Pediatric visceral leishmaniasis in Western Sicily, Italy: a retrospective analysis of 111 cases.
Cascio A; Colomba C; Antinori S; Orobello M; Paterson D; Titone L
Eur J Clin Microbiol Infect Dis; 2002 Apr; 21(4):277-82. PubMed ID: 12072938
[TBL] [Abstract][Full Text] [Related]
8. Comparative analysis of pediatric and adult visceral leishmaniasis in Brazil.
Rocha NA; Oliveira MJ; Franco LF; Júnior GB; Alves MP; Sampaio AM; Montenegro BR; Vieira AP; Jacinto CN; Abreu KL; Daher EF
Pediatr Infect Dis J; 2013 May; 32(5):e182-5. PubMed ID: 23249921
[TBL] [Abstract][Full Text] [Related]
9. Atypical disseminated leishmaniasis resembling post-kala-azar dermal leishmaniasis in an HIV-infected patient.
Boumis E; Chinello P; Della Rocca C; Paglia MG; Proietti MF; Petrosillo N
Int J STD AIDS; 2006 May; 17(5):351-3. PubMed ID: 16643688
[TBL] [Abstract][Full Text] [Related]
10. [Epidemiological situation of visceral leishmaniasis on the Island of São Luis, State of Maranhão].
Silva AR; Tauil PL; Cavalcante MN; Medeiros MN; Pires BN; Gonçalves Eda G
Rev Soc Bras Med Trop; 2008; 41(4):358-64. PubMed ID: 18853007
[TBL] [Abstract][Full Text] [Related]
11. Immunologic tests in patients after clinical cure of visceral leishmaniasis.
De Almeida Silva L; Romero HD; Prata A; Costa RT; Nascimento E; Carvalho SF; Rodrigues V
Am J Trop Med Hyg; 2006 Oct; 75(4):739-43. PubMed ID: 17038704
[TBL] [Abstract][Full Text] [Related]
12. Treatment of cutaneous leishmaniasis recidivans with a combination of allopurinol and meglumine antimoniate: a clinical and histologic study.
Esfandiarpour I; Dabiri SH
Int J Dermatol; 2007 Aug; 46(8):848-52. PubMed ID: 17651170
[TBL] [Abstract][Full Text] [Related]
13. Oral miltefosine treatment in children with mild to moderate Indian visceral leishmaniasis.
Sundar S; Jha TK; Sindermann H; Junge K; Bachmann P; Berman J
Pediatr Infect Dis J; 2003 May; 22(5):434-8. PubMed ID: 12792385
[TBL] [Abstract][Full Text] [Related]
14. Pediatric visceral leishmaniasis in Albania.
Lita G; Davachi F; Sulcebe G; Bregu H; Basha M
Int J Infect Dis; 2002 Mar; 6(1):66-8. PubMed ID: 12044305
[TBL] [Abstract][Full Text] [Related]
15. Efficacy and tolerability of miltefosine for childhood visceral leishmaniasis in India.
Bhattacharya SK; Jha TK; Sundar S; Thakur CP; Engel J; Sindermann H; Junge K; Karbwang J; Bryceson AD; Berman JD
Clin Infect Dis; 2004 Jan; 38(2):217-21. PubMed ID: 14699453
[TBL] [Abstract][Full Text] [Related]
16. Visceral leishmanisis in paediatrics: a study of 367 cases in southwest Iran.
Ashkan MM; Rahim KM
Trop Doct; 2008 Jul; 38(3):186-8. PubMed ID: 18628558
[TBL] [Abstract][Full Text] [Related]
17. Severe adverse reactions to meglumine antimoniate in the treatment of visceral leishmaniasis: a report of 13 cases in the southwestern region of Brazil.
Oliveira AL; Brustoloni YM; Fernandes TD; Dorval ME; Cunha RV; Bóia MN
Trop Doct; 2009 Jul; 39(3):180-2. PubMed ID: 19535762
[TBL] [Abstract][Full Text] [Related]
18. Our experiences in visceral leishmaniasis therapy.
Titone L; Scarlata F; Cascio A; Giordano S; Mancuso G
J Chemother; 1989 Jul; 1(4 Suppl):960-1. PubMed ID: 16312722
[No Abstract] [Full Text] [Related]
19. Visceral leishmaniasis in 13 pediatric patients in Turkey: treatment experience.
Arik Yilmaz E; Tanir G; Tuygun N; Taylan Ozkan A
Turkiye Parazitol Derg; 2009; 33(4):259-62. PubMed ID: 20101572
[TBL] [Abstract][Full Text] [Related]
20. Visceral leishmaniasis during childhood in southern Greece.
Maltezou HC; Siafas C; Mavrikou M; Spyridis P; Stavrinadis C; Karpathios T; Kafetzis DA
Clin Infect Dis; 2000 Nov; 31(5):1139-43. PubMed ID: 11073742
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
